Raymond James & Associates’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.21M | Buy |
|
|||||
|
2024
Q2 | $3.42M | Buy |
|
|||||
|
2024
Q1 | $1.64M | Buy |
|
|||||
|
2023
Q4 | $945K | Sell |
|
|||||
|
2023
Q3 | $1.25M | Sell |
|
|||||
|
2023
Q2 | $1.51M | Sell |
|
|||||
|
2023
Q1 | $1.84M | Buy |
|
|||||
|
2022
Q4 | $1.51M | Sell |
|
|||||
|
2022
Q3 | $1.56M | Sell |
|
|||||
|
2022
Q2 | $1.07M | Buy |
|
|||||
|
2022
Q1 | $1.1M | Buy |
|
|||||
|
2021
Q4 | $1.23M | Buy |
|
|||||
|
2021
Q3 | $734K | Sell |
|
|||||
|
2021
Q2 | $628K | Sell |
|
|||||
|
2021
Q1 | $630K | Sell |
|
|||||
|
2020
Q4 | $6.13M | Buy |
|
|||||
|
2020
Q3 | $4.7M | Buy |
|
|||||
|
2020
Q2 | $3.73M | Buy |
|
|||||
|
2020
Q1 | $2.12M | Sell |
|
|||||
|
2019
Q4 | $3.34M | Buy |
|
|||||
|
2019
Q3 | $1.76M | Buy |
|
|||||
|
2019
Q2 | $2.77M | Buy |
|
|||||
|
2019
Q1 | $2.1M | Buy |
|
|||||
|
2018
Q4 | $1.74M | Sell |
|
|||||
|
2018
Q3 | $3.75M | Buy |
|
|||||
|
2018
Q2 | $2.11M | Sell |
|
|||||
|
2018
Q1 | $1.8M | Sell |
|
|||||
|
2017
Q4 | $1.35M | Sell |
|
|||||
|
2017
Q3 | $1.13M | Buy |
|
|||||
|
2017
Q2 | $355K | Buy |
|
|||||
|
2017
Q1 | $217K | Sell |
|
|||||
|
2016
Q4 | $279K | Sell |
|
|||||
|
2016
Q3 | $1.32M | Buy |
|
|||||
|
2016
Q2 | $289K | Buy |
|
|||||
|
2016
Q1 | $251K | Buy |
|
|||||
|
2015
Q4 | $466K | Buy |
|
|||||
|
2015
Q3 | $370K | Buy |
|
|||||
|
2015
Q2 | $320K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $242K | Buy |
|
|||||
|
2014
Q3 | $283K | Hold |
|
|||||
|
2014
Q2 | $400K | Buy |
|
|||||
|
2014
Q1 | $241K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $1.6M | Sell |
|
|||||
|
2013
Q2 | $2.28M | Buy |
|